Twist Bioscience Corp (NASDAQ: TWST)’s stock price has gone rise by 1.00 in comparison to its previous close of 45.07, however, the company has experienced a 9.29% increase in its stock price over the last five trading days. businesswire.com reported 2024-08-27 that SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Baird Global Healthcare Conference 2024 in New York City on Tuesday, September 10 at 2:35 p.m. Eastern Time. The presentation will be webcast live and can be accessed by visiting the “I.
Is It Worth Investing in Twist Bioscience Corp (NASDAQ: TWST) Right Now?
Additionally, the 36-month beta value for TWST is 1.77. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for TWST is 56.11M and currently, short sellers hold a 15.51% ratio of that float. The average trading volume of TWST on October 18, 2024 was 840.50K shares.
TWST’s Market Performance
TWST stock saw a decrease of 9.29% in the past week, with a monthly decline of -3.19% and a quarterly a decrease of -15.55%. The volatility ratio for the week is 5.87%, and the volatility levels for the last 30 days are 4.46% for Twist Bioscience Corp (TWST). The simple moving average for the past 20 days is 2.16% for TWST’s stock, with a 9.03% simple moving average for the past 200 days.
Analysts’ Opinion of TWST
Many brokerage firms have already submitted their reports for TWST stocks, with Guggenheim repeating the rating for TWST by listing it as a “Buy.” The predicted price for TWST in the upcoming period, according to Guggenheim is $53 based on the research report published on June 04, 2024 of the current year 2024.
Goldman, on the other hand, stated in their research note that they expect to see TWST reach a price target of $45, previously predicting the price at $25. The rating they have provided for TWST stocks is “Buy” according to the report published on January 17th, 2024.
Berenberg gave a rating of “Buy” to TWST, setting the target price at $27 in the report published on September 27th of the previous year.
TWST Trading at 3.54% from the 50-Day Moving Average
After a stumble in the market that brought TWST to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.25% of loss for the given period.
Volatility was left at 4.46%, however, over the last 30 days, the volatility rate increased by 5.87%, as shares sank -5.15% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.18% upper at present.
During the last 5 trading sessions, TWST rose by +9.29%, which changed the moving average for the period of 200-days by +31.41% in comparison to the 20-day moving average, which settled at $44.56. In addition, Twist Bioscience Corp saw 23.49% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TWST starting from Laponis Adam, who sale 856 shares at the price of $41.81 back on Oct 09 ’24. After this action, Laponis Adam now owns 73,397 shares of Twist Bioscience Corp, valued at $35,791 using the latest closing price.
Laponis Adam, the Officer of Twist Bioscience Corp, proposed sale 856 shares at $41.81 during a trade that took place back on Oct 09 ’24, which means that Laponis Adam is holding shares at $35,791 based on the most recent closing price.
Stock Fundamentals for TWST
Current profitability levels for the company are sitting at:
- -0.64 for the present operating margin
- 0.41 for the gross margin
The net margin for Twist Bioscience Corp stands at -0.75. The total capital return value is set at -0.34. Equity return is now at value -38.36, with -30.42 for asset returns.
Based on Twist Bioscience Corp (TWST), the company’s capital structure generated 0.15 points at debt to capital in total, while cash flow to debt ratio is standing at -0.8. The debt to equity ratio resting at 0.18. The interest coverage ratio of the stock is -189969.0.
Currently, EBITDA for the company is -193.21 million with net debt to EBITDA at 0.99. When we switch over and look at the enterprise to sales, we see a ratio of 8.52. The receivables turnover for the company is 8.95for trailing twelve months and the total asset turnover is 0.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.91.
Conclusion
In conclusion, Twist Bioscience Corp (TWST) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
